Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (154)
  • 2024 (226)
  • 2023 (287)
  • 2022 (350)
  • 2021 (156)
  • 2020 (29)
  • 2019 (6)
  • 2018 (1)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4016)
  • Synthetic drugs (1067)
  • OCDETF/Task Force (810)
  • Fake Pills (655)
  • Arrests/Convictions - Major (605)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (458)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Diversion Division (243)
  • Task Forces/Task Force Officers (231)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (111)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (7)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Guns/Weapons (990)
  • Pharmaceuticals/Pharmacists/Physicians (224)

Drug Name

  • Fentanyl (493)
  • Cocaine (416)
  • Methamphetamine (378)
  • Heroin (228)
  • Marijuana (Cannabis) (90)
  • Oxycodone (71)
  • Opioids (51)
  • Synthetic Opioids (31)
  • Ecstasy/MDMA (16)
  • Hydromorphone (12)
  • Benzodiazepines (7)
  • Ketamine (7)
  • Morphine (7)
  • Steroids (4)
  • Amphetamines (3)
  • Methadone (3)
  • Psilocybin (3)
  • K2/Spice (2)
  • LSD (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Synthetic Bath Salts or Designer Cathinones (1)
  • Xylazine (1)

Field Division

  • New England (278)
  • St. Louis (147)
  • Chicago (132)
  • Washington, DC (130)
  • New York (95)
  • Seattle (94)
  • El Paso (50)
  • Miami (47)
  • New Jersey (45)
  • Atlanta (37)
  • San Francisco (33)
  • Dallas (28)
  • Sede (17)
  • Houston (15)
  • Phoenix (14)
  • Los Angeles (10)
  • Louisville (8)
  • New Orleans (8)
  • San Diego (8)
  • Rocky Mountain (7)
  • Omaha (6)
  • Detroit (2)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

EDVA Forfeits Over 164 Illegal Firearms and Prosecutes 250 Illegal Firearms Offenders in 2022

Diciembre 19, 2022
ALEXANDRIA, Va. – Jessica D. Aber, United States Attorney for the Eastern District of Virginia, announced that over the course of the past year (2022), EDVA’s litigative efforts have resulted in the forfeiture of at least 164 illegally owned, possessed, used, or obtained firearms. Firearms that are criminally forfeited are...
Diciembre 19, 2022
PRESS RELEASE

Doctor and Office Manager Indicted in Scheme to Defraud Medicare, Manufacture and Distribute Fentanyl

Diciembre 16, 2022
SAN DIEGO - Dr. David J. Smith, a pain management physician, and his office manager, Julia Ann Oertle, are charged in a federal grand-jury indictment with perpetuating a long-running scheme to commit healthcare fraud and to manufacture and distribute adulterated fentanyl. Smith made his initial appearance today before U.S. Magistrate...
Diciembre 16, 2022
PRESS RELEASE

Drug Trafficker Sentenced to 7 Years for Operating Cocaine Delivery Service in Chicago Area

Diciembre 16, 2022
CHICAGO — Robert J. Bell, Special Agent in Charge of Drug Enforcement Administration-Chicago Division, and U.S. Attorney John R. Lausch, Jr., for the Northern District of Illinois announced that a drug trafficker who conspired with his father and several others to operate a cocaine delivery service in the Chicago area...
Diciembre 16, 2022
PRESS RELEASE

DEA Serves Order to Show Cause on Truepill Pharmacy for its Involvement in the Unlawful Dispensing of Prescription Stimulants

Diciembre 15, 2022
WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...
Diciembre 15, 2022
PRESS RELEASE

11 Members of Bronx “Wash” Gang Charged with Murder, Racketeering, and Related Violent Offenses

Diciembre 14, 2022
NEW YORK - Damian Williams, the United States Attorney for the Southern District of New York, Frank A. Tarentino III, Special Agent in Charge of the New York Office of the Drug Enforcement Administration (“DEA”), and Keechant L. Sewell, Commissioner of the New York City Police Department (“NYPD”), announced the...
Diciembre 14, 2022
PRESS RELEASE

Multi-Agency Investigation Shuts Down Violent Drug Trafficking Ring

Diciembre 14, 2022
ROCHESTER, N.Y. – On Wednesday, December 14, 2022, multiple law enforcement agencies utilized information collected from a long-term narcotics investigation to execute search warrants at seventeen locations within the City of Rochester; Town of Sweden, and Town of Greece. This was a long-term investigation by the Monroe County District Attorney’s...
Diciembre 14, 2022
PRESS RELEASE

Bronx Man Indicted Following Seizure of Approximately $2.5 Million Worth of Powdered Fentanyl and Fentanyl Pills

Diciembre 14, 2022
NEW YORK CITY – An indictment filed by the Office of the Special Narcotics Prosecutor charges Eric Hooks in connection with the seizure of approximately 8 kilograms of powdered fentanyl (over 17 pounds) and up to 10,000 counterfeit pills allegedly containing fentanyl from a vehicle and an apartment in the...
Diciembre 14, 2022
PRESS RELEASE

Kansas Pharmacy Agrees to Pay $3 Million for Improperly Dispensing Meds

Diciembre 13, 2022
KANSAS CITY, Kan. - PharmScript of KS, LLC, a long-term care pharmacy in Lenexa, Kansas, has agreed to pay $3 million to resolve allegations that it violated federal law by dispensing controlled substances to residents in nursing and long-term care facilities without valid prescriptions and that the company was wrongfully...
Diciembre 13, 2022
PRESS RELEASE

Doctor and Eight Others Charged with Distributing Opioids and Other Pills

Diciembre 09, 2022
MANHATTAN – Manhattan District Attorney Alvin L. Bragg, Jr., today announced the indictments of nine individuals, including Tribeca physician Dr. Noel Smith, for charges including conspiring to distribute tens of thousands of prescription pills, including opioids and other controlled substances, in Manhattan and Staten Island. The defendants allegedly operated a...
Diciembre 09, 2022
PRESS RELEASE

Northeast Hospital Agrees to Pay $1.9 Million To Resolve Allegations of Controlled Substance Recordkeeping Violations

Diciembre 07, 2022
BOSTON – Northeast Hospital Corporation (Northeast), part of Beth Israel Lahey Health, has agreed to pay $1.9 million in civil penalties to resolve allegations that Northeast violated the Controlled Substance Act (the CSA) by failing to keep accurate records of controlled substances, including opioids. The CSA requires accurate inventorying and...
Diciembre 07, 2022
Showing 681 - 690 of 1212 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 65
  • Página 66
  • Página 67
  • Página 68
  • Current page 69
  • Página 70
  • Página 71
  • Página 72
  • Página 73
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster